NCT07241663Recruiting
Surgery for Locally Unresectable Pancreatic Cancer
Conversion Surgery for Locally Unresectable Pancreatic Cancer - International Multi-center Observational Trial (ROBIN= suRgery for lOcally unresectaBle pancreatIc Cancer)
Source: ClinicalTrials.gov · Last updated 26 Nov 2025
Brief summary (registry, in English)
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Azienda Ospedaliera di Padova
- Diseases
- Pancreatic cancer
- NCT number
- NCT07241663
What you commit to
- Study type: Observational
- Planned participants: 150
- From 1 Jan 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of tumor characteristics precluding surgery
- Presence of patient significant comorbidities precluding surgery
- Unavailable pre-induction therapy abdominal imaging
Other
- Informed consent withdrawal
- Pathological confirmation of any tumor different from PDAC
Who the study is looking for
- Patients older than 18 years
- Patients able to give informed consent
- Histologically confirmed pancreatic adenocarcinoma
- LAPC stage according to NCCN10 at diagnosis (Figure 1)
- Received at least 4 months of induction chemotherapy
- RECIST 1.1 stable disease (SD) or partial response (PR) after induction therapy
- Patient considered eligible for radical resection by local MDT
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UOC Chirurgia Generale 2, Azienda Ospedale di Padova, Padova, Italy 35128 Coordinator of this site? Confirm its status | Padova | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.